Free tool
Stocks listed on Nasdaq CM
We cover 20 companies listed on Nasdaq CM. The median market value in the group is $17.43M. Across the group, the median move over the past trading day is +0.67%. 90% of the 20 with a 200-day average trade above it. Price change over the past year runs from −42.1% to +305.0% across the middle 80 percent of the group, with a median of +9.1%.
Other lists in this group
Table
20 of 1,344 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% |
| DWTX | Dogwood Therapeutics, Inc. | $90.42M | Micro cap | −42.80% |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% |
| PRPO | Precipio, Inc. | $54.43M | Micro cap | +99.25% |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% |
| HBIO | Harvard Bioscience, Inc. | $34.83M | Micro cap | +44.34% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +8660.74% |
| LEXX | Lexaria Bioscience Corp. | $18.24M | Micro cap | +1146.05% |
| BCDA | BioCardia, Inc. | $18.02M | Micro cap | −38.66% |
| CMMB | Chemomab Therapeutics Ltd. | $16.85M | Micro cap | −25.57% |
| APRE | Aprea Therapeutics, Inc. | $12.34M | Micro cap | −38.75% |
| LUCY | Lucyd, Inc | $9.73M | Micro cap | −42.05% |
| FBLG | FibroBiologics, Inc. | $9.39M | Micro cap | −88.25% |
| XBIO | Xenetic Biosciences, Inc. | $9.04M | Micro cap | +35.92% |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% |
| CURX | Curanex Pharmaceuticals Inc | $7.21M | Micro cap | −1.29% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.48M | Micro cap | +211.51% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.48M | Micro cap | +93.92% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.